Evaluation of Skin Cleansers and Skin Protectants in Management of Incontinence-associated Dermatitis

Not Applicable

Terminated

Interventions: Device: Conveen EasiCleanse and Conveen Critic Barrier
Device: Standard cleansing and Conveen Critic Barrier
Device: 3M Cavilon No-Rinse Skin Cleanser and 3M Cavilon Advanced Skin Protectant

Brief Summary: The aim of this study is to evaluate the efficacy of two different skin care regimens (3M Cavilon Advanced Skin Protectant with 3M No-Rinse Cleanser and Coloplast Conveen Critic Barrier with Easi-Cleanser) against standard care (Skin wipes and Conveen Critic Barrier) in the management of Incontinence-Associated Dermatitis (IAD) in hospitalised patients

Detailed Description: The aim of this study is to evaluate the efficacy of two different skin care regimens (3M Cavilon Advanced Skin Protectant with 3M No-Rinse Cleanser and Coloplast Conveen Critic Barrier with Easi-Cleanser) against standard care (Skin wipes and Conveen Critic Barrier) in the management of Incontinence-Associated Dermatitis (IAD) in hospitalised patients.

To date, there is no conclusive evidence on the "best treatment" for patients presenting with IAD. This has led to current clinical practices tend to select IAD products based on its cost and availability, which can be heavily influenced by marketing and commercialisation efforts.

This study allows investigation of the effectiveness of IAD products to ensure the provision of optimal care.

Recruitment & Eligibility

Inclusion Criteria

Exclusion Criteria

Having a known allergy to the treatment products
Haemodynamically unstable at point of assessment for study
Unable to tolerate lateral positioning for skin cleansing and treatment application
Pregnancy
Having an existing skin disease at point of study that might lead to inaccurate IAD assessment, such as herpes or scabies.

Arm && Interventions

Group	Intervention	Description
Conveen EasiCleanse and Conveen Critic Barrier	Conveen EasiCleanse and Conveen Critic Barrier	Skin cleanser: Conveen EasiCleanse. Skin protectant: Conveen Critic Barrier (zinc oxide-based barrier cream). After each episode of incontinence, the skin cleanser was also first used to cleanse the skin, followed by application of the barrier cream, as per the barrier cream manufacturer's instructions.
Soap and water / Incontinence wipes and Conveen Critic Barrier	Standard cleansing and Conveen Critic Barrier	Skin cleanser: Ordinary soap and water or incontinence wipes. Skin protectant: Conveen Critic Barrier (zinc oxide-based barrier cream). After each episode of incontinence, the skin was cleansed using soap and water or incontinence wipes, followed by application of the barrier cream.
3M No-Rinse Cleanser and 3M Cavilon Advanced Skin Protectant	3M Cavilon No-Rinse Skin Cleanser and 3M Cavilon Advanced Skin Protectant	Skin cleanser: 3M No-Rinse Cleanser. Skin protectant: 3M Cavilon Advanced Skin Protectant (liquid acrylic tetrapolymer skin protectant layer). The skin cleanser was used during every episode of incontinence and the protectant was applied every three days as recommended by the manufacturer.

Primary Outcome Measures

Name	Time	Method
Proportion of Participants With IAD Healing	Up to seven days from initiation of treatment	Percentage of participants who experienced IAD healing
Number of Participants Who Experienced IAD Healing	Up to seven days from initiation of treatment	Total number of participants who experienced IAD healing

Secondary Outcome Measures

Name	Time	Method
Number of Participants Who Developed Skin Loss	Up to three days from initiation of treatment	Examination of the development of skin loss using the Ghent Global IAD Categorisation tool (GLOBIAD). Binary scoring, 1 and 2. Higher value (2) indicates worse outcome (Development of skin loss)